|
[1]
|
Zhang, Y., Zhang, S., Li, B.L., et al. (2022) Gut Microbiota Dysbiosis Promotes Age-Related Atrial Fibrillation by Lip-opolysaccharide and Glucose-Induced Activation of NLRP3-Inflammasome. Cardiovascular Research, 118, 785-797. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Tabata, T., Yamashita, T., Hosomi, K., et al. (2021) Gut Microbial Com-position in Patients with Atrial Fibrillation: Effects of Diet and Drugs. Heart and Vessels, 36, 105-114. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Inceu, A.-I., Neag, M.-A., Craciun, A.-E., et al. (2023) Gut Molecules in Cardiometabolic Diseases: The Mechanisms behind the Story. International Journal of Molecular Sciences, 24, Article No. 3385. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Gawałko, M., Agbaeden, T.A., Saljic, A., et al. (2022) Gut Microbiota, Dysbiosis and Atrial Fibrillation. Arrhythmogenic Mechanisms and Potential Clinical Implications. Cardiovascular Re-search, 118, 2415-2427. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Menichelli, D., Carnevale, R., Nocella, C., et al. (2021) Circulating Lipo-polysaccharides and Impaired Antioxidant Status in Patients with Atrial Fibrillation. Data from the ATHERO-AF Study. Frontiers in Cardiovascular Medicine, 8, Article ID: 779503. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Carnevale, R., Nocella, C., Petrozza, V., et al. (2018) Localization of Lipopolysaccharide from Escherichia coli into Human Atherosclerotic Plaque. Scientific Reports, 8, Article No. 3598. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Xu, J. and Yang, Y.J. (2021) Gut Microbiome and Its Me-ta-Omics Perspectives: Profound Implications for Cardiovascular Diseases. Gut Microbes, 13, e1936379. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Corban, M.T., Toya, T., et al. (2021) Atrial Fibrillation and Endothelial Dysfunction: A Potential Link? Mayo Clinic Proceedings, 96, 1609-1621. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Yang, Z.H., Wang, Q.C., Liu, Y.X., et al. (2023) Gut Microbi-ota and Hypertension: Association, Mechanisms and Treatment. Clinical and Experimental Hypertension, 45, 2195135. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Manner, I.W., Baekken, M., Kvale, D., et al. (2013) Markers of Microbial Translocation Predict Hypertension in HIV-Infected Individuals. HIV Medicine, 14, 354-361. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Verhaar, B.J.H., Prodan, A., Nieuwdorp, M., et al. (2020) Gut Microbiota in Hypertension and Atherosclerosis: A Review. Nutrients, 12, Article No. 2982. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Aune, D., Mahamat-Saleh, Y., Kobeissi, E., et al. (2023) Blood Pressure, Hypertension and the Risk of Atrial Fbrillation: A Systematic Review and Meta-Analysis of Cohort Studies. European Journal of Epidemiology, 38, 145-178. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Cao, X., Broughton, S.T., Waits, G.S., et al. (2019) Interrela-tions between Hypertension and Electrocardiographic Left Ventricular Hypertrophy and Their Associations with Cardio-vascular Mortality. American Journal of Cardiology, 123, 274-283. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Gumprecht, J., Domek, M., Lip, G.Y.H. and Shantsila, A. (2019) Invited Review: Hypertension and Atrial Fibrillation: Epidemiology, Pathophysiology, and Implications for Man-agement. Journal of Human Hypertension, 33, 824-836. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Blöbaum, L., Witkowski, M., Wegner, M., et al. (2023) Intestinal Barrier Dysfunction and Microbial Translocation in Patients with First-Diagnosed Atrial Fibrillation. Biomedicines, 11, Article No. 176. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Kong, B., Fu, H., Xiao, Z., et al. (2022) Gut Microbiota Dysbiosis Induced by a High-Fat Diet Increases Susceptibility to Atrial Fibrillation. Canadian Journal of Cardiology, 38, 1962-1975. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Zhan, X., Cheng, L., Huo, N., et al. (2022) Sodi-um-Glucose Cotransporter-2 Inhibitor Alleviated Atrial Remodeling in STZ-Induced Diabetic Rats by Targeting TLR4 Pathway. Frontiers in Cardiovascular Medicine, 9, Article ID: 908037. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Wang, M., Xiong, H., Lu, L., et al. (2022) Serum Lipopolysaccha-ride Is Associated with the Recurrence of Atrial Fibrillation after Radiofrequency Ablation by Increasing Systemic In-flammation and Atrial Fibrosis. Oxidative Medicine and Cellular Longevity, 2022, Article ID: 2405972. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Pastori, D., Carnevale, R., Nocella, C., et al. (2017) Gut-Derived Serum Lipopolysaccharide Is Associated with Enhanced Risk of Major Adverse Cardiovascular Events in Atrial Fibrillation: Ef-fect of Adherence to Mediterranean Diet. Journal of the American Heart Association, 6, e005784. [Google Scholar] [CrossRef]
|
|
[20]
|
Zhou, W.Y., Cheng, Y.Y., Zhu, P., et al. (2020) Implication of Gut Microbiota in Cardiovascular Diseases. Oxidative Medicine and Cellular Longevity, 2020, Article ID: 5394096. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Smits, L.P., Kootte, R.S., Levin, E., et al. (2018) Effect of Vegan Fecal Microbiota Transplantation on Carnitine- and Choline-Derived Trimethylamine-N-Oxide Production and Vascular In-flammation in Patients with Metabolic Syndrome. Journal of the American Heart Association, 7, e008342. [Google Scholar] [CrossRef]
|
|
[22]
|
de Almeida, S.M., Mowry, F.E., Peaden, S.C., Andrade, T.U. and Biancardi, V.C. (2020) Kefir Ameliorates Hypertension via Gutbrain Mechanisms in Spontaneously Hypertensive Rats. The Journal of Nutritional Biochemistry, 77, Article ID: 108318. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Ghosh, S.S., Bie, J., Wang, J. and Ghosh, S. (2014) Oral Sup-plementation with Non-Absorbable Antibiotics or Curcumin Attenuates Western Diet-Induced Atherosclerosis and Glu-cose Intolerance in LDLR-/- Mice-Role of Intestinal Permeability and Macrophage Activation. PLOS ONE, 9, e108577. [Google Scholar] [CrossRef] [PubMed]
|